Allscripts-Misys Healthcare - Comparative Multiple Analysis

Allscripts-Misys Healthcare (Comparative Multiple Analysis)

placeholder_large_analysis.png
Banner%20-%20The%20perfect%20tool%20for%20investors%281%29.gif

Notes on the Comparative Multiple Analysis of Allscripts-Misys Healthcare

WikiWealth compares Allscripts-Misys Healthcare's revenue, EBITDA, and EBIT multiples to their peers in order to determine the appropriate fair valuation. Click in the top right corner to experiment with Allscripts-Misys Healthcare's comparative analysis.

Notes from the analysis:

1. WikiWealth uses quantitative measures to determine the multiple range for Allscripts-Misys Healthcare.
2. Free cash flow to the firm (FCF) multiple is free cash flow to equity holders plus interest owed to Allscripts-Misys Healthcare's debt holders.
3. Multiples incorporate benefits due to economies of scale; WikiWealth compares absolute enterprise value multiples to competitor's multiples.
4. WikiWealth excludes outliers when calculating individual company multiples.

Helpful Information for Allscripts-Misys Healthcare's Analysis


How does this work? The Comparative Investment Analysis determines the value of Allscripts-Misys Healthcare by comparing Allscripts-Misys Healthcare financial ratios, prices, growth rates, margins, etc. to those of relevant peer groups.

Value Investing Importance? This method is widely used by investment professionals to determine the correct price of investments, especially initial public offerings (IPOs). It is one element of WikiWealth's three Wall Street approaches used to determine the correct fair value of Allscripts-Misys Healthcare.

See the Allscripts-Misys Healthcare cash flow (DCF) analysis for a completely different approach that's popular on Wall Street for determining the value of an investment in Allscripts-Misys Healthcare.

Also, see the Allscripts-Misys Healthcare's buffett intrinsic valuation analysis for WikiWealth's attempt to replicate the investing formula's used by Warren Buffett and Allscripts-Misys Healthcare's valuation conclusion for a quick summary.